PA
IMCC

Parallel Advisors’s IM Cannabis IMCC Stock Holding History

Parallel Advisors’s Portfolio IMCC Stock Details IMCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 3439
2022
Q3 		$0 Hold
1
– – ﹤0.01% 3312
2022
Q2 		$0 Hold
1
– – ﹤0.01% 3154
2022
Q1 		$0 Buy
+1
New +$136 ﹤0.01% 3103

Other funds holding IMCC

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BMCM
Black Maple Capital Management Milwaukee, Wisconsin $179M AUM 8.19% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Parallel Advisors's IMCC Position: Q4 2022 in Review

Parallel Advisors sold out of IM Cannabis (IMCC) in Q4 2022, closing a stake of 1 share.

Parallel Advisors first reported a position in IMCC in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 18 funds tracked by Wall St. Rank hold IMCC as of Q4 2022.

  • Parallel Advisors reported no remaining IM Cannabis position as of Q4 2022 after selling out during the quarter.
  • Parallel Advisors sold 1 IM Cannabis share in Q4 2022.
  • Parallel Advisors first reported a position in IM Cannabis in Q1 2022 and held it in 3 quarters.
  • Parallel Advisors's IM Cannabis position peaked at $0 in Q3 2022.
  • 18 funds tracked by Wall St. Rank held IM Cannabis as of Q4 2022.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.